| Literature DB >> 3060373 |
P G Hartman1, M Stähli, H P Kocher, R L Then.
Abstract
The existence of two distinct dihydrofolate reductases (DHFR) in highly trimethoprim-resistant clinical isolates has been unequivocally demonstrated. The enzymes have been characterized with regard to the affinity for substrates and sensitivity to inhibitors. The chromosomal, trimethoprim-sensitive DHFR was purified to homogeneity by a new simple two-step procedure. Its N-terminal amino acid sequence, determined up to the first 35 amino acids, showed 69% homology with the Escherichia coli DHFR.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3060373 DOI: 10.1016/0014-5793(88)81006-8
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124